HIF‐1α regulates the cell viability in radioiodine‐resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF‐κB signaling pathway
出版年份 2023 全文链接
标题
HIF‐1α regulates the cell viability in radioiodine‐resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF‐κB signaling pathway
作者
关键词
-
出版物
MOLECULAR CARCINOGENESIS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-10-20
DOI
10.1002/mc.23648
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- ALKBH5‐induced circular RNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2
- (2023) Xiaoyu Ji et al. CANCER SCIENCE
- HIF-1 Interacts with TRIM28 and DNA-PK to release paused RNA polymerase II and activate target gene transcription in response to hypoxia
- (2022) Yongkang Yang et al. Nature Communications
- DYRK1A suppression attenuates HIF‑1α accumulation and enhances the anti‑liver cancer effects of regorafenib and sorafenib under hypoxic conditions
- (2022) Chong Zhang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
- (2022) Qinghua Wu et al. Journal of Hematology & Oncology
- Immunohistochemical Expression of CD44, MMP-2, MMP-9, and Ki-67 as the Prognostic Markers in Non-Clear Cell Renal Cell Carcinomas—A Prospective Cohort Study
- (2022) Magdalena Chrabańska et al. Journal of Clinical Medicine
- The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis
- (2021) Fang Zheng et al. Nature Communications
- Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study
- (2021) Maria Papaleontiou et al. THYROID
- The role of PKM2 nuclear translocation in the constant activation of the NF-κB signaling pathway in cancer-associated fibroblasts
- (2021) Junjie Gu et al. Cell Death & Disease
- The PDZ protein SCRIB regulates sodium/iodide symporter (NIS) expression at the basolateral plasma membrane
- (2021) Mariano Martín et al. FASEB JOURNAL
- Loss of FAM83H promotes cell migration and invasion in cutaneous squamous cell carcinoma via impaired keratin distribution
- (2021) Keiko Tokuchi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Correlation of 68Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: a prospective translational exploratory study
- (2021) Christine E. Mona et al. JOURNAL OF NUCLEAR MEDICINE
- Mesenchymal stromal cell apoptosis is required for their therapeutic function
- (2021) Swee Heng Milon Pang et al. Nature Communications
- PKM2 suppresses osteogenesis and facilitates adipogenesis by regulating β-catenin signaling and mitochondrial fusion and fission
- (2020) Jiachao Guo et al. Aging-US
- TNFα-mediated activation of NF-κB downregulates sodium-iodide symporter expression in thyroid cells
- (2020) Márcia Faria et al. PLoS One
- Thyroid cancer surgery – in what direction are we going? A mini-review
- (2020) Krzysztof Kaliszewski et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Radioiodine-induced salivary gland damage detected by ultrasonography in patients treated for papillary thyroid cancer: RAI activity and risk
- (2020) Eleonora Horvath et al. THYROID
- Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology
- (2020) Hilda Samimi et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Mediator complex subunit 16 is down-regulated in papillary thyroid cancer, leading to increased transforming growth factor-β signaling and radioiodine resistance
- (2020) Hongwei Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Assessing non-aggressiveness of untreated, local and regional, papillary thyroid cancer
- (2020) Maaike van Gerwen et al. ORAL ONCOLOGY
- PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer
- (2020) Maria Sfakianaki et al. Cancers
- Metabolic enzyme pyruvate kinase M2 regulates platelet function and arterial thrombosis
- (2020) Manasa K. Nayak et al. BLOOD
- Changes in Population-Level and Institutional-Level Prescribing Habits of Radioiodine Therapy for Papillary Thyroid Cancer
- (2020) Daniel Jacobs et al. THYROID
- Immunohistochemical expression of CD44, matrix metalloproteinase2 and matrix metalloproteinase9 in renal cell carcinomas
- (2019) Yong-Moon Lee et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Phenotypic selection with an intrabody library reveals an anti-apoptotic function of PKM2 requiring Mitofusin-1
- (2019) Tong Liu et al. PLOS BIOLOGY
- Novel targeted therapies and immunotherapy for advanced thyroid cancers
- (2018) George E. Naoum et al. Molecular Cancer
- Differentiated thyroid cancer theranostics: radioiodine and beyond
- (2018) Partha Choudhury et al. BRITISH JOURNAL OF RADIOLOGY
- The Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer
- (2018) Cesidio Giuliani et al. Frontiers in Endocrinology
- Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial
- (2018) Hakim-Moulay Dehbi et al. Lancet Diabetes & Endocrinology
- Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase
- (2017) Xianling Ning et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- New Insights in Thyroid Cancer and p53 Family Proteins
- (2017) Livia Manzella et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation
- (2016) Ninel Azoitei et al. Molecular Cancer
- Inhibiting β-catenin expression promotes efficiency of radioiodine treatment in aggressive follicular thyroid cancer cells probably through mediating NIS localization
- (2016) Ling Lan et al. ONCOLOGY REPORTS
- Div-Seq: Single-nucleus RNA-Seq reveals dynamics of rare adult newborn neurons
- (2016) Naomi Habib et al. SCIENCE
- MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis
- (2016) Muhammad Zain Mehdi et al. International Braz J Urol
- Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue
- (2015) Paul Kachel et al. BMC CANCER
- Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages
- (2015) Eva M. Palsson-McDermott et al. Cell Metabolism
- Aberrant Overexpression of Pyruvate Kinase M2 Is Associated With Aggressive Tumor Features and theBRAFMutation in Papillary Thyroid Cancer
- (2013) Chen Feng et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Thyroid cancer: Surgery for the primary tumor
- (2013) I.J. Nixon et al. ORAL ONCOLOGY
- Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
- (2011) Weibo Luo et al. CELL
- Role of NF-κB in thyroid cancer
- (2009) Francesco Pacifico et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Galectin-3 Targeted Therapy with a Small Molecule Inhibitor Activates Apoptosis and Enhances Both Chemosensitivity and Radiosensitivity in Papillary Thyroid Cancer
- (2009) C.-I. Lin et al. MOLECULAR CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now